Current Clinical Trials
ELIOS - Clinical Trial
A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Effectiveness of the ELIOS System to Reduce Intraocular Pressure in Patients With Primary Open-Angle Glaucoma Undergoing Cataract Surgery
You may be eligible to participate in a clinical study for ELIOS™ Technology. To qualify, you must:
- Be at least 45 years old
- Have glaucoma and use glaucoma medications
- Have a cataract
Participation includes exams to assess your eye health, follow-up care for up to 2 years, and reimbursement of up to $1,075 for costs associated with time and travel.
Sponsor: ELIOS Vision, Inc
iSTAR - Clinical Trial
A Prospective, Multicenter Masked Clinical Trial to Evaluate the Safety and Effectiveness of the MINIject CS627 Implant in Subjects With Open Angle Glaucoma
Do you have open angle glaucoma?
If you have been told by your eye doctor that you have glaucoma, you may be able to participate in a clinical study. To qualify you must:
- Be 46 years of age or older
- Be diagnosed with Open Angle Glaucoma (POAG)
- Have had cataract surgery
- Meet all other study-related criteria
The MINIijectTM implant is an investigational medical device made of 100% medical grade silicone designed to lower intraocular pressure (IOP) in primary open angle glaucoma. The MINIijectTM procedure is designed to be less invasive than traditional glaucoma surgery and is performed using microsurgical incisions.
Sponsor: iSTAR Medical
ESTHER - Clinical Trial
Esther Clinical Trial for Glaucoma and Ocular Hypertensive Patients
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients
You may be eligible to participate in a clinical study for ESTHER. To qualify, you must meet one of the following requirements:
- Have glaucoma
- Have ocular hypertension
We want to help protect vision.
Sponsor: Laboratory Corporation of America® Holdings